Julian Gill

Traditionally, compounding pharmacies exist to serve a small subset of patients who have specialized medical needs. But millions have taken compounded GLP-1s.

According to internal financial records, the pharmacy dispensed nearly 3 million individual prescriptions to patients nationwide during the first 10 months of 2024, drawing $311 million in...

O ver the last decade, the U.S. Food and Drug Administration has issued four warning letters after uncovering numerous red flags inside Empower Pharmacy's two drug production facilities in Houston.

Compounded drugs sold for cash prices don’t generate billing records that would allow regulators to track basic information, like who is taking the drug and what happens after treatment.

Empower Pharmacy calls itself the largest and most advanced compounding pharmacy in the country.

The Houston Chronicle began reporting on drug quality concerns at Empower Pharmacy back in April 2025, after receiving a tip about a former employee

Today, the scale at which most compounding pharmacies produce drugs — and the frequency of problems arising from their products — remains largely unknown.

A Houston Chronicle investigation found that the public is left in the dark when it comes to patient harm associated with the drugs.

While Houston’s largest hospitals are all adopting AI in radiology, some move slower than others, citing high costs and uncertainty about its potential to improve health outcomes.

Houston, with its concentration of sprawling hospitals, is primed to become a proving ground for artificial intelligence in medicine.